According to IMARC Group latest report titled “Parenteral Nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on parenteral nutrition market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
The global parenteral nutrition market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.
Parenteral nutrition, a specialized medical solution delivered intravenously, provides nourishment to those unable to obtain adequate nutrients orally or enterally. It is a life-sustaining therapy for patients with gastrointestinal dysfunction, ensuring they receive essential vitamins, minerals, carbohydrates, proteins, and fats. This clinical nutrition is classified into two types: total parenteral nutrition (TPN), which bypasses the gastrointestinal tract entirely, and partial parenteral nutrition (PPN), which supplements oral intake.
Advantages of parenteral nutrition include tailored nutrient composition to meet individual patient needs, immediate nutrient utilization by the body, and the ability to bypass the need for gastrointestinal processing. Critical for patients with compromised digestive systems, parenteral nutrition supports the maintenance of energy, growth, and overall health, thereby playing a pivotal role in the medical management of critically ill and postoperative patients.
Get a Sample Copy of this Report: https://www.imarcgroup.com/parenteral-nutrition-market/requestsample
Market Trends:
The global parenteral nutrition market is majorly driven by a rising incidence of chronic conditions that impair oral nutrient absorption, such as Crohn's disease, cancer, and ischemic bowel disease. Along with this, technological advancements in the formulation and administration of parenteral nutrition enhance patient safety and efficacy of treatment, which, in turn, provides a boost to the market. In addition, the escalating number of preterm births requiring immediate and specialized nutritional support is favoring the market.
Moreover, the ongoing research and development of new parenteral formulations aim to reduce the risk of infection and improve patient outcomes, fostering market expansion. Apart from this, the rise in healthcare expenditures and the development of home healthcare services are also contributing to the increased demand for parenteral nutrition, offering patients the convenience of at-home treatment. Furthermore, the emergence of multi-chamber bags, which simplify the mixing and administration process, is creating a positive market outlook.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/parenteral-nutrition-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Aculife Healthcare Private Limited
- Braun Melsungen AG
- Baxter International Inc.
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Otsuka Pharmaceutical Factory Inc.
- Pfizer Inc.
- Servona GmbH
Parenteral Nutrition Market Segmentation:
Our report has categorized the market based on region, nutrient type and end use.
Breakup by Nutrient Type:
- Carbohydrates
- Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins and Minerals
Breakup by End User:
- Hospitals
- Clinics
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Comments